Fall 2006
Vol. 16, Number 3


IDSA Releases Updated Lyme Disease Guidelines


IDSA has updated its clinical practice guidelines on Lyme disease, significantly expanding their scope from that of the guidelines published nearly six years ago.Deer Tick Photo

Panel Chair Gary P. Wormser, MD, FIDSA, said the panel “added more information on epidemiology, clinical features, and the diagnosis” of Lyme disease, adding that they wanted to develop guidelines that were “as comprehensive as possible.” They will be published in the Nov. 1 issue of Clinical Infectious Diseases, and are now available online.

The new guidelines include recommendations on two additional tick-borne diseases, human granulocytic anaplasmosis (HGA) and babesiosis, which are also transmitted by the deer tick, Ixodes scapularis. Lyme disease is the most common tick-borne infection in North America and Europe, but a bite from I. scapularis may lead to the development of Lyme disease, HGA, babesiosis or, less frequently, coinfection.

Along with several new recommendations, there is one substantive change to the previous recommendations. Dr. Wormser notes, “We now recommend that selected high-risk tick bites may be treated with a single dose of doxycycline for people who are eligible for the drug.”

The panel also went into much greater detail in the new guidelines to discuss post-Lyme disease syndromes. “We explain what the term refers to,” Dr. Wormser says, “and thoroughly go over the evidence to justify our recommendation against antibiotic treatment.”

The guidelines propose a definition for post-Lyme disease syndrome, as there has been no well-accepted definition to date. The panel asserted that objective evidence of prior B. burgdorferi infection must be part of any acceptable definition of post-Lyme disease syndrome.

The guidelines do not recommend antibiotic therapy for those with chronic symptoms who have received the recommended treatment for Lyme disease. “No convincing biologic evidence exists for symptomatic chronic B. burgdorferi infection in patients after recommended treatment regimens for Lyme disease,” the guidelines state.

The guidelines are available online on our website, www.idsociety.org, under “Practice Guidelines.”

< Previous Article | Next Article >

Congratulations to this year’s 30 outstanding scholars!
IDSA and HIVMA Announce New Board Members
IDSA Members on the Move
Principles on Adolescent, Adult Immunization Shared with NVAC
Readers Offer Feedback On Newsletter, Other Communications
2006 Awards: Society and HIVMA Awards
Welcome, New IDSA Members!
ACGME Rejects IDSA/HIVMA Request on Oversease Fellowships
Chinese Prime Minister Visits IDI
Senate Appropriations Bill Highlights Fight Against Antimicrobial Resistance
Join the Emerging Infections Network
HIVMA Symposium Tackles Media Coverage of HIV Science
New Brochure Promotes ID Specialty
ID/HIV Career Center Offers Member Discount
Flu Vaccines Education Materials Available
NIH Offers Loan Repayment for Clinical Research
New CMS Rules May Block Billing for Initial Consultations
Medicare Reimbursement Cuts Looming - Again
Medicare Urged Not to Unfairly Penalize Hospital Infections
Second Clinical Practice Meeting Planned for 2007
New CME Monograph, JID Supplement Provide Latest in Influenza Science
IDSA Releases Updated Lyme Disease Guidelines
White House, Others Seek IDSA Input on Pandemic Flu, Disaster Preparedness
Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA